Events & Presentations

Date	Title
Dec 8, 2024 5:00 PM EST	Updated Data in Multiple Myeloma and First Data in non-Hodgkin’s Lymphoma from the Ongoing Phase 1/2 Trial of Cemsidomide Presented at ASH 2024 Click here for Webcast
Nov 20, 2024 4:00 AM EST	Jefferies London Healthcare Conference Click here for Webcast
Sep 18, 2024 8:35 AM EDT	2024 Cantor Global Healthcare Conference Click here for Webcast
Sep 13, 2024 12:00 PM EDT	Preliminary Monotherapy Results from the Ongoing Phase 1 Trial of CFT1946 Presented at ESMO Congress Click here for Webcast
Sep 5, 2024 8:45 AM EDT	Wells Fargo Healthcare Conference 2024 Click here for Webcast

Date	Title
December 9, 2024	Corporate Presentation – December 2024
December 9, 2024	Cemsidomide Phase 1 Dose Escalation Data in MM and NHL
December 8, 2024	ASH 2024 - Initial Results of a Phase 1 Trial of Monotherapy Cemsidomide in Non-Hodgkin’s Lymphoma
December 8, 2024	ASH 2024 – Initial Results of Phase 1 Trial of Cemsidomide with Dexamethasone in Multiple Myeloma
October 30, 2024	TPD Summit - Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946, a BRAF V600 Mutant Degrader, for Solid Tumors

Past Events